Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

Moderna Jumps On Unexpected First-Quarter Profit Amid Plummeting Covid Sales

Moderna stock jumped Thursday on an unexpected first-quarter gain even as sales plummeted amid waning demand for Covid vaccines.

Investors Business Daily

GSK Stock Jumps After Beating Pfizer, Moderna To The RSV Vaccine Finish Line

GSK stock jumped Wednesday after the drugmaker won the first-ever approval for an RSV vaccine, leading rivals Pfizer and Moderna.

Investors Business Daily

Attorney General Ken Paxton to investigate COVID-19 vaccine makers

Long an opponent of vaccine and mask mandates, the Republican said pharmaceutical companies may have misrepresented data. Pfizer strongly disagrees.

The Texas Tribune

From analysis to the latest developments in health,
read the most diverse news in one place.

Lyme disease: vaccine could halt rise of tick-borne disease

A vaccine for Lyme disease could be available soon, according to reports.

The Week

Moderna's CEO shares what it was like to leap from pre-revenue startup to Fortune 500 company

The COVID-19 vaccine turned Moderna into a household name. What's next for the company?

Fortune

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review

The major indexes saw modest declines, holding in a range. Tesla sold off as gross margins plunged. ISRG and DHI were earnings winners.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Novavax Plummets On Downgrade: Is It The Covid Engine That Couldn't?

Novavax has a solid platform but continues to face a $700 million litigation headwind, an analyst said Thursday as he downgraded NVAX stock.

Investors Business Daily

Bearish Option Trade For MRNA Stock

With low implied volatility right now, a bear put spread on Moderna is a viable strategy to profit on the downside.

Investors Business Daily

Extra spring COVID booster cleared for certain Americans

Certain Americans at high risk from COVID-19 can get an extra vaccine booster this spring

The Independent UK

S&P 500: Top 5 Performers Today Include Enphase Energy, First Solar

The five best S&P 500 performers Monday included Enphase Energy and First Solar. Moderna was a key laggard. Banks were big winners and losers.

Investors Business Daily

Moderna Crumbles As Cancer Vaccine Data Show A 'Longish And Complex' Road

Moderna stock crumbled Monday after updated results for its Merck-partnered cancer vaccine show a "longish and complex path" toward approval.

Investors Business Daily

Stock Market Slides After Mixed Bank Earnings, Meta Downgrade, Google's AI Trauma

Google parent Alphabet sold off more than 3% after Samsung considered ditching the search engine.

Investors Business Daily

Autumn Covid booster 2023: Who is eligible for another jab?

If invited, you will receive a booster dose of a Covid-19 vaccine made by Pfizer, Moderna, or Sanofi

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

The Week

Sanofi: the new protein-based Covid vaccine to be used in the UK

The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.

Tribune News Service

Study: Vaccine helps drug keep melanoma patients cancer-free

Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation of a key study.

Wales Online

Everything we know about new Sanofi Covid vaccine now being used in UK

The vaccine being used in the Spring booster campaign works in a different way to previous jabs

The Conversation

Sanofi vaccine: what to know about this protein-based COVID booster being offered in the UK

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Moderna Stock Skids Below Key Line On Unexpected Flu Shot Debacle

Moderna stock skidded Tuesday on a mixed update for its mRNA-based flu vaccine. The update could impact the shot's commercial timing.

Investors Business Daily

Moderna Stock Yo-Yoes Winning A Key Battle For Its Cancer Vaccine

Moderna stock rose Monday after European regulators granted its Merck-partnered personalized cancer vaccine a key designation.

Wales Online

Cancer and heart disease vaccines could be ready 'by the end of the decade'

The speed of which the Covid jab was developed has "unspooled" medical advancements

Manchester Evening News

Vaccines for cancer could be ready by 2030, according to Moderna chief

The pharmaceutical firm said it is confident the jabs for cancer could be ready by the end of the decade

The Independent UK

‘Groundbreaking’ cancer and heart disease vaccine ‘could save millions of lives’

Experts hope new vaccines will be ready by end of decade

The Guardian - UK

‘A silver lining’: how Covid ushered in a vaccines golden era

Pandemic accelerated advances in vaccine technology, opening up possibilities for combating array of diseases

The Guardian - UK

Cancer and heart disease vaccines ‘ready by end of the decade’

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.